An Bang Lu
Net worth: 16 M $ as of 31/05/2026
Net worth: 16 M $ as of 31/05/2026
An Bang Lu is currently Chief Executive Officer & Executive Director at VISEN Pharmaceuticals (Shanghai) Co., Ltd. and Chief Executive Officer & Executive Director at VISEN Pharmaceuticals since 2021.
Formerly, Mr. Lu was President, General Manager & Head-Greater China at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014.
Education includes an undergraduate degree from Taipei Medical University, conferred in 1989.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/01/2026 | 5,326,250 ( 4.68% ) | 16 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| VISEN PHARMACEUTICALS | Chief Executive Officer | 07/11/2018 |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | President | 01/01/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Taipei Medical University
Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Health Technology |
VISEN Pharmaceuticals
VISEN Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes paradigm-shifting endocrine therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions